Trabectedin shows activity in ATREUS trial in patients with sarcomatoid malignant mesothelioma



PharmaMar has announced data from a Phase 2 study in patients with sarcomatoid/biphasic malignant pleural mesothelioma showing that 41.2% (95% CI: 18.4-67.



Source link

sticket2

Would you like to get the test?

This entry was posted in Uncategorized. Bookmark the permalink.